About Mitofam
Add Pedigree
Help
About Mitofam
Add Pedigree
Help
MT-COX1
A6307G
A6474G
A7222G
A7222G-F1
A7299G
A7445C
A7445G
A7445G-F6
A7445G-F5
A7445G-F4
A7445G-F7
A7445T
C6328T
C6489A
C6489A-F1
C6597A
C6597A-F1
G5906A
G5913A-F1
G5913A
G5920A
G6261A
G6480A
G6480A-F1
G6579A
G6708A
G6955A
G6962A
G7023A
G7444A
G7444A-F21
G7444A-F9
T6459C
T6459C-F1
T6526C
T6547C
T6721C
T6742C
G6930A
Edit by Mitofam Team
-
+
首页
G6480A-F1
**Figure 1\. Pedigree diagram for family G6480A\-F1\.**  # Pedigree Information | **No.** | **Position** | **Variant** | **Family ID** | **Nationality** | **Diseases** | **Unaffected Maternal Relatives** | **Affected Maternal Relatives** | **Publication Year** | **PMID/Ref** | **Note** | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1 | 6480 | m.6480G\>A | G6480A\-F1 | Chinese | Leber hereditary optic neuropathy | 10 | 18 | 2008 | [19022198](https://pubmed.ncbi.nlm.nih.gov/19022198/) | Carrying G11778A, T12811C, A15395G | The **m.6480G\>A** variant in MT\-CO1 was reported in family G6480A\-F1 from Chinese with leber hereditary optic neuropathy. The pedigree record reported 10 unaffected and 18 affected maternal relatives, and the carrier table includes 29 listed carriers. Homoplasmy was reported in 1/29 listed carriers; 19/29 carriers were affected, and the main clinical manifestation among affected carriers was lhon, visual impairment, bilateral visual impairment. # Carrier Information | **No.** | **Position** | **Variant** | **Family ID** | **Carrier ID** | **Type (Fam/De novo/Uninf)** | **Gender (F/M)** | **Proband (Y/N)** | **Affected (Y/N)** | **Die/Alive(D/A)** | **Age** | **Blood Mutant Level** | **Muscle Mutant level** | **Urine Mutant level** | **Other Mutant level** | **Clinical Features** | **Note** | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1 | 6480 | m.6480G\>A | G6480A\-F1 | G6480A\-F1\-I\-2 | Uninf | F | N | N | ND | ND | / | / | / | / | Healthy | | | 2 | 6480 | m.6480G\>A | G6480A\-F1 | G6480A\-F1\-II\-2 | Fam | F | N | Y | ND | ND | / | / | / | / | LHON; visual impairment | | | 3 | 6480 | m.6480G\>A | G6480A\-F1 | G6480A\-F1\-II\-3 | Fam | M | N | Y | ND | ND | / | / | / | / | LHON; visual impairment | | | 4 | 6480 | m.6480G\>A | G6480A\-F1 | G6480A\-F1\-II\-5 | Fam | F | N | Y | ND | ND | / | / | / | / | LHON; visual impairment | | | 5 | 6480 | m.6480G\>A | G6480A\-F1 | G6480A\-F1\-III\-1 | Fam | M | N | Y | ND | ND | / | / | / | / | LHON; visual impairment | | | 6 | 6480 | m.6480G\>A | G6480A\-F1 | G6480A\-F1\-III\-2 | Fam | M | N | Y | ND | ND | / | / | / | / | LHON; visual impairment | | | 7 | 6480 | m.6480G\>A | G6480A\-F1 | G6480A\-F1\-III\-4 | Fam | F | N | N | ND | ND | / | / | / | / | Healthy | | | 8 | 6480 | m.6480G\>A | G6480A\-F1 | G6480A\-F1\-III\-5 | Fam | F | N | N | ND | ND | / | / | / | / | Healthy | | | 9 | 6480 | m.6480G\>A | G6480A\-F1 | G6480A\-F1\-III\-6 | Fam | M | N | N | ND | ND | / | / | / | / | Healthy | | | 10 | 6480 | m.6480G\>A | G6480A\-F1 | G6480A\-F1\-III\-7 | Fam | M | N | N | ND | ND | / | / | / | / | Healthy | | | 11 | 6480 | m.6480G\>A | G6480A\-F1 | G6480A\-F1\-III\-9 | Fam | F | N | Y | ND | ND | / | / | / | / | LHON; visual impairment | | | 12 | 6480 | m.6480G\>A | G6480A\-F1 | G6480A\-F1\-III\-10 | Fam | M | N | Y | ND | ND | / | / | / | / | LHON; visual impairment | | | 13 | 6480 | m.6480G\>A | G6480A\-F1 | G6480A\-F1\-III\-12 | Fam | F | N | Y | ND | ND | / | / | / | / | LHON; visual impairment | | | 14 | 6480 | m.6480G\>A | G6480A\-F1 | G6480A\-F1\-III\-14 | Fam | F | N | Y | ND | ND | / | / | / | / | LHON; visual impairment | | | 15 | 6480 | m.6480G\>A | G6480A\-F1 | G6480A\-F1\-III\-15 | Fam | M | N | Y | ND | ND | / | / | / | / | LHON; visual impairment | | | 16 | 6480 | m.6480G\>A | G6480A\-F1 | G6480A\-F1\-III\-17 | Fam | F | N | Y | ND | ND | / | / | / | / | LHON; visual impairment | | | 17 | 6480 | m.6480G\>A | G6480A\-F1 | G6480A\-F1\-IV\-1 | Fam | F | N | N | ND | ND | / | / | / | / | Healthy | | | 18 | 6480 | m.6480G\>A | G6480A\-F1 | G6480A\-F1\-IV\-2 | Fam | F | N | N | ND | ND | / | / | / | / | Healthy | | | 19 | 6480 | m.6480G\>A | G6480A\-F1 | G6480A\-F1\-IV\-3 | Fam | M | N | Y | ND | ND | / | / | / | / | LHON; visual impairment | | | 20 | 6480 | m.6480G\>A | G6480A\-F1 | G6480A\-F1\-IV\-4 | Fam | F | N | N | ND | ND | / | / | / | / | Healthy | | | 21 | 6480 | m.6480G\>A | G6480A\-F1 | G6480A\-F1\-IV\-5 | Fam | F | N | Y | ND | ND | / | / | / | / | LHON; visual impairment | | | 22 | 6480 | m.6480G\>A | G6480A\-F1 | G6480A\-F1\-IV\-6 | Fam | M | N | Y | ND | ND | / | / | / | / | LHON; visual impairment | | | 23 | 6480 | m.6480G\>A | G6480A\-F1 | G6480A\-F1\-IV\-7 | Fam | M | Y | Y | ND | 28 | Homo | / | / | / | LHON; bilateral visual impairment | Carrying G11778A, T12811C, A15395G | | 24 | 6480 | m.6480G\>A | G6480A\-F1 | G6480A\-F1\-IV\-9 | Fam | F | N | N | ND | ND | / | / | / | / | Healthy | | | 25 | 6480 | m.6480G\>A | G6480A\-F1 | G6480A\-F1\-IV\-10 | Fam | M | N | Y | ND | ND | / | / | / | / | LHON; visual impairment | | | 26 | 6480 | m.6480G\>A | G6480A\-F1 | G6480A\-F1\-IV\-11 | Fam | M | N | Y | ND | ND | / | / | / | / | LHON; visual impairment | | | 27 | 6480 | m.6480G\>A | G6480A\-F1 | G6480A\-F1\-IV\-12 | Fam | F | N | Y | ND | ND | / | / | / | / | LHON; visual impairment | | | 28 | 6480 | m.6480G\>A | G6480A\-F1 | G6480A\-F1\-IV\-13 | Fam | M | N | Y | ND | ND | / | / | / | / | LHON; visual impairment | | | 29 | 6480 | m.6480G\>A | G6480A\-F1 | G6480A\-F1\-V\-1 | Fam | F | N | N | ND | ND | / | / | / | / | Healthy | | For abbreviations and other usage instructions, please see [Mitofam Info](https://mitofam.com/doc/385/).
Haoying Chen
2026年6月26日 16:35
转发
收藏文档
上一篇
下一篇
手机扫码
复制链接
手机扫一扫转发分享
复制链接
分享
链接
类型
密码
更新密码
有效期
Markdown文件
Word文件
PDF文档
PDF文档(打印)